Kamada (KMDA) Stock Highlights

5.9 | +0.85%

2024-12-21 05:50:38

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Statistics

Range Today

5.83 5.99

Volume Today 17.7K

Range 1 Year

4.74 6.53

Volume 1 Year 7.73M

Range 3 Year

3.72 6.96

Volume 3 Year 26.17M

Range 10 Year

3.19 13.33

Volume 10 Year 150.97M

Highlights

Market Capitalization 344.95M (small)

Floating Shares 10.22M

Current Price 5.9

Price To Earnings 22.19

Price To Revenue 1.84

Price To Book 1.32

Earnings Per Share 0.27

Payout Ratio 0%

Performance

Latest +0.85%

1 Month 0%

3 Months +9.26%

6 Months +18.47%

1 Year -1.34%

3 Years -10.47%

5 Years -15.47%

10 Years +63.43%

Benchmarks

Market Capitalization

30 / 54

Gross Profits

29 / 39

Total Revenue

30 / 50

Total Rank

42 / 54

Free Cashflow

37 / 54

Performance 5 years

18 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.